Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/08/2003WO2002024226A9 Photosensitisers
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2002009702A8 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/08/2003WO2002008194A8 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
05/08/2003WO2001091763A9 Extracts from spermatophyte plants with antitumor activity
05/08/2003WO2001075454A3 Diagnosis and treatment of alzheimer's disease
05/08/2003US20030088312 Use of cladribine on a stent to prevent restenosis
05/08/2003US20030088236 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
05/08/2003US20030088199 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030088106 Process for purifying 6-methoxy omeprazole
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030088101 E-ring expanded camptothecin derivatives
05/08/2003US20030088099 Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
05/08/2003US20030088096 Preparation by cleavage of triazolopyrimidines or by cyanoamination of sulfonylpyrimidines
05/08/2003US20030088092 Water-soluble porphyrin derivatives and methods of their preparation
05/08/2003US20030088061 Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing an allosteric regulatory site
05/08/2003US20030087965 Including neuropathic pain.
05/08/2003US20030087964 Method and pharmaceutical composition for the treatment of cancer
05/08/2003US20030087963 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
05/08/2003US20030087962 Anti-inflammatory, anti-pain and vasoconstrictive arthroscopic surgical irrigation solutions.
05/08/2003US20030087961 Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
05/08/2003US20030087960 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
05/08/2003US20030087959 Caused by stroke, trauma, carbon monoxide poisoning, and other poisonings; increasing choline aceytltransferase activity; administering methanesulfonyl fluoride or ethanesulfonyl fluoride
05/08/2003US20030087957 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
05/08/2003US20030087956 Useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor alpha 4 beta 1.
05/08/2003US20030087951 Has cytotoxicity in 7 human tumor cell lines
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087949 For treating neurodegenerative diseases, diseases of circulatory organs, hepatitis, renal diseases, inflammatory skin disorders, radiation disorders, viral diseases, prion diseases, etc.; preservatives
05/08/2003US20030087948 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
05/08/2003US20030087947 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photodynamic therapy
05/08/2003US20030087946 Inhibits tumor cell growth
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087944 Such as a 1H-indole-3-glyoxylamide.
05/08/2003US20030087942 Method for the treatment and prevention of cachexia
05/08/2003US20030087941 Administering a dopamine D1, D2, D3, and D4 receptor agonist such as pramipexole or talipexole.
05/08/2003US20030087938 Treatment of chronic pain with 3-heterocycloxy-and 3-cycloalkyloxy-3-phenylpropanamines
05/08/2003US20030087937 Nicotine replacement therapy.
05/08/2003US20030087936 Treating enterovirus infection
05/08/2003US20030087934 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
05/08/2003US20030087933 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
05/08/2003US20030087932 Sulfuric acid mono-[ 3- ( {1- [ 2- (4-fluoro-phenyl ) -ethyl ] -piperidin-4-YL} -hydroxy-methyl) -2-methoxy-phenyl ] ester
05/08/2003US20030087931 Nitrogen heteroaromatic ring connected with the same or another aromatic ring through a triazine distribution agent; anticancer agents
05/08/2003US20030087930 Process for preparing 2-(4-chlorobenzolamino)-3[ (1h)-quinolinon-4-yl] propionic acid
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087924 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
05/08/2003US20030087923 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087921 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
05/08/2003US20030087919 Rho-kinase inhibitors
05/08/2003US20030087917 Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system
05/08/2003US20030087916 Pyrimidin-4-one compounds
05/08/2003US20030087913 Solid pharmaceutical agent formulation for a piperazine urea derivative
05/08/2003US20030087912 Aryl oxime-piperazines useful as CCR5 antagonists
05/08/2003US20030087911 Methods and compositions for treating hypertension
05/08/2003US20030087910 E.g., O-(2-quinolinylmethyl)-N-quinaldoyl-D,L-tyrosine
05/08/2003US20030087907 Quinoline derivatives and quinazoline derivatives having azolyl group
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087900 Treating cancer, especially leukemia and breast cancer, by administering a compound that inhibits the expression of the TPT1 gene, such as hydroxyzine or promethazine.
05/08/2003US20030087899 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound.
05/08/2003US20030087898 Opioid receptor antagonists; treating irritable bowel syndrome, drug addiction or dependency, depression, and eating disorders.
05/08/2003US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis
05/08/2003US20030087896 Characterized by dissociation
05/08/2003US20030087895 Fused imidazole derivatives as multidrug resistance modulators
05/08/2003US20030087894 Vitronectin receptor antagonist
05/08/2003US20030087893 Compositions containing alpha-2-adrenergic agonist components
05/08/2003US20030087892 Condensed azepines as vasopressin agonists
05/08/2003US20030087889 Photodynamic therapy of occult age-related macular degeneration
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087887 Gonane derivative antibiotics
05/08/2003US20030087886 Orally active androgens
05/08/2003US20030087884 Aldosterone receptor antagonist; side effect reduction
05/08/2003US20030087883 Therapeutic 5-HT ligand compounds
05/08/2003US20030087880 Hydroxy-benzoic acid derivatives; bactericides
05/08/2003US20030087878 Methods and formulations for minimizing spasticity in blood vessel grafts
05/08/2003US20030087876 Amino derivative of a disaccharide and an oxidized disaccharide or a derivative
05/08/2003US20030087875 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
05/08/2003US20030087873 Treating a Flaviviridae, Orthomyxoviridae or Paramyxoviridae infection
05/08/2003US20030087872 Fucosidase 32616 is differentially expressed in tumor and/or angiogenic tissue samples as compared to normal tissue samples
05/08/2003US20030087868 Administration of a vector to cells in vivo comprising and expressing a transgene encoding beta-glucosidase, the vector is taken up by the cells, the transgene is expressed therein and and beta-glucosidase is produced
05/08/2003US20030087866 Suppression of malignancy utilizing ribonucleotide reductase R1
05/08/2003US20030087861 Administering mixture of antibody and drug; cancer sensitivity
05/08/2003US20030087857 Antisense modulation of insulin-like growth factor binding protein 5 expression
05/08/2003US20030087848 Antihistamines, antiallergens
05/08/2003US20030087845 Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
05/08/2003US20030087844 Ribavirin syrup formulations
05/08/2003US20030087842 Indolocarbazole anticancer agents and methods of using them
05/08/2003US20030087841 Disaccharide derivatives for treating hyperglycaemia
05/08/2003US20030087840 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
05/08/2003US20030087839 Combined preparations comprising morpholine anthracyclines and anticancer agent
05/08/2003US20030087838 Mixture containing spinosyn a and d
05/08/2003US20030087837 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
05/08/2003US20030087836 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
05/08/2003US20030087834 Administering tagatose
05/08/2003US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis
05/08/2003US20030087830 Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof
05/08/2003US20030087829 Central nervous system disorders
05/08/2003US20030087822 Parathyroid hormone antagonists and uses thereof